Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6

PaperCitations, authors & open-access status

Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6 is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 988 citations, 2015 year and closed oa status.

988
Citations
2015
Year
closed
OA Status

Related on ScholarIQ

James Chih‐Hsin Yang
Author
Chong‐Jen Yu
Author
Nobuyuki Yamamoto
Author
Lecia V. Sequist
Author
Yi‐Long Wu
Author
The Lancet Oncology
Journal
470M+ articles · free account